0000950170-24-076894.txt : 20240624 0000950170-24-076894.hdr.sgml : 20240624 20240624172002 ACCESSION NUMBER: 0000950170-24-076894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cloonan Michael CENTRAL INDEX KEY: 0001704336 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 241065350 MAIL ADDRESS: STREET 1: C/O SAGE THERAPEUTICS, INC. STREET 2: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 GRAND UNION BOULEVARD CITY: SOMERVILLE STATE: MA ZIP: 02145 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 455 GRAND UNION BOULEVARD CITY: SOMERVILLE STATE: MA ZIP: 02145 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 ownership.xml 4 X0508 4 2024-06-20 0001293971 bluebird bio, Inc. BLUE 0001704336 Cloonan Michael C/O BLUEBIRD BIO, INC 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 true false false false false Stock Option (right to buy) 0.85 2024-06-20 4 A false 74775 0.00 A 2034-06-20 Common Stock 74775 74775 D The stock option vests with respect to one third of the shares on each of the first three anniversaries of the grant date. /s/ Sydney Gaylin, Attorney-in-Fact 2024-06-24